Loading…Loading…
At the Benzinga Cannabis Capital Conference in Hollywood, Florida, Constantin von der Groeben, managing director of Demecan, declared a pivotal moment for global cannabis legislation.
‘We’ve reached a tipping point. I think there’s no stepping back from Germany’s cannabis legalization,’ von der Groeben said during Tuesday’s panel.
See Also: It’s A Matter Of When: Cresco Labs CEO Forecasts Cannabis Rescheduling And Industry Reform
The discussion, moderated by Tim Seymour of Seymour Asset Management, featured insights from key industry leaders including Matt Darin, CEO of Curaleaf CURLF, Laurie Holcomb, CEO of Gold Flora GRAM, and Darren Weiss, president of Verano Holdings VRNOF.
Each shared their perspectives on the evolving global cannabis market, offering insights into how their companies are navigating this dynamic landscape.
Von der Groeben elaborated on the economic implications for Germany, now poised as a market of 84 million people, one of the largest economies worldwide and “probably a role model for other European countries” in the cannabis realm.
He also highlighted the complexities of navigating this highly regulated market. “The German market is pharma-heavy, demanding high-quality production standards and strict regulatory compliance. This opens up opportunities for technology and innovation in cultivation and distribution.”
Cannabis Markets: Europe Vs. The U.S.
Darin provided insights into
